Crossmark

Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial

Crossref DOI link: https://doi.org/10.1186/s13054-019-2361-5

Published Online: 2019-02-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pennisi, Mariano Alberto

Bello, Giuseppe

Congedo, Maria Teresa

Montini, Luca

Nachira, Dania

Ferretti, Gian Maria

Meacci, Elisa

Gualtieri, Elisabetta

De Pascale, Gennaro

Grieco, Domenico Luca

Margaritora, Stefano

Antonelli, Massimo
License Information

Text and Data Mining valid from 2019-02-28
More Information

Article History

Received: 21 December 2018

Accepted: 17 February 2019

First Online: 28 February 2019

Ethics approval and consent to participate

: The study was approved by local Ethics Committee and written informed consent to data analysis was obtained by all studied patients

: Not applicable

: MA has received payments for board participation from Maquet, Air Liquide, and Chiesi. MA and DLG disclose a research grant received by General Electrics Health Care. DLG has received payments for travel expenses by Maquet, Getinge, and Air Liquide and is supported by grants from SIAARTI/Merck Sharp & Dohme and ESICM (2017 Bernhard Dräger Award for Advanced Treatment of Acute Respiratory Failure). All other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.